SIB accelerates the path from discovery to economic value

UniProt and the Swiss Personalized Health Network are two examples of how SIB supports Switzerland’s innovation ecosystem by making data accessible and usable.

Opinion editorial by Jérôme Wojcik, Industrial Data Scientist, Entrepreneur, Chairman of the SIB Board of Directors

High-quality data infrastructure supports Swiss competitiveness

Switzerland consistently tops global innovation and competitiveness rankings, supported in no small part by decades of strong federal investment in education, research and innovation.

Within this framework, high-quality infrastructure that makes data accessible and usable — like that developed collaboratively by SIB for the life sciences — plays a critical role.

Two examples show what that means in practice for the Swiss innovation ecosystem. UniProt, an SIB Resource, contributes directly to Swiss pharma patents and boosts researcher productivity, as measured in an economic analysis. And the Swiss Personalized Health Network offers opportunities to gain insights for new healthcare solutions from real-world patient data, including through a first pilot with a pharmaceutical company.

See more on the UniProt analysis

See more on the SPHN pilot

Biodata resources and infrastructure need ongoing investment

These and other biodata resources and infrastructure provided and coordinated by SIB similarly accelerate the path from discovery to economic value across the life sciences. As budgets tighten, this is exactly the kind of investment that Switzerland cannot afford to cut.

– Originally published in the SIB Profile 2026

Join #GenevaLovesData this summer to discover further examples of biodata supporting Swiss innovation.